Cargando…

Usefulness of the Optimal Cutoff Value and Delta Value of Leucine-Rich Alpha 2 Glycoprotein in Ulcerative Colitis

BACKGROUND: Leucine-rich alpha 2 glycoprotein (LRG) is a novel serum biomarker used to determine disease activity in inflammatory bowel disease. We investigated the association between endoscopic scores based on the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and LRG in ulcerative coliti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Satohiro, Mashima, Hirosato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681229/ https://www.ncbi.nlm.nih.gov/pubmed/36778513 http://dx.doi.org/10.1093/crocol/otac039

Ejemplares similares

Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn’s Disease: Is There Any Difference between Small Intestine and Colonic Lesions?
por: Matsumoto, Satohiro, et al.
Publicado: (2023)

Real-World Long-Term Remission Maintenance for 10 Years With Thiopurines in Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2021)

Efficacy of Combined Mesalazine Plus Corticosteroid Enemas for Diversion Colitis after Subtotal Colectomy for Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2016)

Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis
por: Tsuboi, Rumiko, et al.
Publicado: (2018)

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis
por: Shinzaki, Shinichiro, et al.
Publicado: (2017)

Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases
por: Kawamura, Haruna, et al.
Publicado: (2017)

Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort study
por: Matsumoto, Satohiro, et al.
Publicado: (2017)

Serum Leucine-Rich α2 Glycoprotein: A Biomarker for Predicting the Presence of Ulcerative Colitis but Not Ulcerative Proctitis
por: Horiuchi, Ichitaro, et al.
Publicado: (2022)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto, Satohiro, et al.
Publicado: (2018)

Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
por: Matsumoto, Satohiro, et al.
Publicado: (2020)

Serum leucine‐rich alpha‐2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy‐naïve cases with ulcerative colitis
por: Kono, Masashi, et al.
Publicado: (2023)

Combined serum albumin, fecal immunochemical test, and leucine-rich alpha-2 glycoprotein levels for predicting prognosis in remitting patients with ulcerative colitis
por: Nakamura, Naohiro, et al.
Publicado: (2023)

Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis
por: Fujimoto, Minoru, et al.
Publicado: (2020)

Construction of a preoperative scoring system to predict the difficulty level of colorectal endoscopic submucosal dissection
por: Matsumoto, Satohiro, et al.
Publicado: (2019)

Does long-term efficacy differ between infliximab and adalimumab after 1 year of continuous administration?: A STROBE-compliant retrospective cohort study
por: Otake, Haruka, et al.
Publicado: (2017)

A Case with Serrated Polyposis Syndrome Controlled by Multiple Applications of Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection
por: Suzuki, Daisuke, et al.
Publicado: (2017)

Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
por: Otake, Haruka, et al.
Publicado: (2022)

The Prognostic Value of Leucine-Rich α2 Glycoprotein 1 in Pediatric Spinal Cord Injury
por: Ma, Hong, et al.
Publicado: (2021)

Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection
por: Kajimoto, Etsuko, et al.
Publicado: (2020)

Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review
por: Zou, Yonghui, et al.
Publicado: (2022)

Leucine-Rich Alpha-2-Glycoprotein: A Novel Predictor of Diastolic Dysfunction
por: Loch, Alexander, et al.
Publicado: (2023)

Post-ERCP biliary complications in patients with biliary type sphincter of Oddi dysfunction
por: Miyatani, Hiroyuki, et al.
Publicado: (2018)

Clinical course of biliary-type sphincter of Oddi dysfunction: endoscopic sphincterotomy and functional dyspepsia as affecting factors
por: Miyatani, Hiroyuki, et al.
Publicado: (2019)

Clinical features and management of painless biliary type sphincter of Oddi dysfunction
por: Miyatani, Hiroyuki, et al.
Publicado: (2019)

Should Emergency Endoscopy be Performed in All Patients With Suspected Colonic Diverticular Hemorrhage?
por: Uehara, Takeshi, et al.
Publicado: (2017)

A case of gossypiboma diagnosed with transanal double-balloon enteroscopy
por: Ishii, Takehiro, et al.
Publicado: (2018)

C‐reactive protein predicts the development of walled‐off necrosis in patients with severe acute pancreatitis
por: Fujiwara, Junichi, et al.
Publicado: (2021)

Endoscopic Mucosal Incision to Remove a Fish Bone Completely Embedded Under the Esophageal Mucosa: A Case Report and Literature Review
por: Koito, Yudai, et al.
Publicado: (2022)

Efficacy of Ustekinumab Against Spondyloarthritis Associated with Crohn’s Disease: A Case Report and Review of the Literature
por: Matsumoto, Satohiro, et al.
Publicado: (2020)

Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma
por: Honda, Hiromi, et al.
Publicado: (2016)

Leucine-rich alpha-2-glycoprotein 1 and angiotensinogen as diagnostic biomarkers for Kawasaki disease
por: Yanagimachi, Masakatsu, et al.
Publicado: (2021)

Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides
por: Umezawa, Natsuka, et al.
Publicado: (2023)

Leucine-Rich Alpha-2 Glycoprotein 1 Accumulates in Complicated Atherosclerosis and Promotes Calcification
por: Grzesiak, Lucile, et al.
Publicado: (2023)

Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn’s Disease
por: Asonuma, Kunio, et al.
Publicado: (2023)

Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Evaluation of the Optimal Position for Vedolizumab in the Japanese Treatment Paradigm for Ulcerative Colitis Using Markov Modeling
por: Uda, Akihito, et al.
Publicado: (2020)

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
por: Andersen, John D, et al.
Publicado: (2010)

Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target
por: Javaid, Faiza, et al.
Publicado: (2021)

Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
por: Yasutomi, Eriko, et al.
Publicado: (2021)

Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis
por: Kerur, Basavaraj, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h10rhbjrqj8ign9nvtrkc7dhq3